Physical and Functional Interactions between Type I Transforming Growth Factor β Receptors and Bα, a WD-40 Repeat Subunit of Phosphatase 2A

REFERENCES

• Alessi, D. R., N. Gomez, G. Moorhead, T. Lewis, S. M. Keyse, and P. Cohen 1995. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr. Biol. 5: 283–295.
   PubMed Web of Science ®Google Scholar
• Andersson, S., D. L. Davis, H. Dahlback, H. Jornvall, and D. W. Russell 1989. Cloning, structure, and expression of the mitrochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264: 8222–8229.
   PubMed Web of Science ®Google Scholar
• Bassing, C. H., J. M. Yingling, D. J. Howe, T. Wang, W. W. He, M. L. Gustafson, P. Shah, P. K. Donahoe, and X.-F. Wang 1993. A transforming growth factor β type I receptor that signals to activate gene expression. Science 263: 87–89.
   Google Scholar
• Brand, T., and M. D. Schneidert 1995. Inactive type II and type I receptors for TGF β are dominant inhibitors of TGF beta-dependent transcription. J. Biol. Chem. 270: 8274–8284.
   PubMedGoogle Scholar
• Cairns, J., S. Qin, R. Philp, Y. H. Tan, and G. R. Guy 1994. Dephosphorylation of the small heat shock protein Hsp27 in vivo by protein phosphatase 2A. J. Biol. Chem. 269: 9176–9183.
   PubMedGoogle Scholar
• Chen, J., S. Parsons, and D. L. Brautigan 1994. Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J. Biol. Chem. 269: 7957–7962.
   PubMedGoogle Scholar
• Chen, R.-H., and R. Derynck 1994. Homomeric interactions between the type II TGF-β receptors. J. Biol. Chem. 269: 22868–22874.
   PubMed Web of Science ®Google Scholar
• Chen, R.-H., P. J. Miettinen, E. M. Maruoka, L. Choy, and R. Derynck 1995. A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature 377: 548–552.
   PubMedGoogle Scholar
• Clarke, P. R., I. Hoffmann, G. Draetta, and E. Karsenti 1993. Dephosphorylation of cdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle in Xenopus egg extracts. Mol. Biol. Cell 4: 397–411.
   PubMedGoogle Scholar
• Cohen, P. 1991. Classification of protein-serine/threonine phosphatases: identification and quantitation in cell extracts. Methods Enzymol. 201: 389–397.
   PubMed Web of Science ®Google Scholar
• Derynck, R., and Y. Zhang 1996. Intracellular signalling: the mad way to do it. Curr. Biol. 6: 1226–1229.
   PubMedGoogle Scholar
• Derynck, R., and X.-H. Feng 1997. TGF-β receptor signaling. BBA Rev. Cancer, 1333: F105–F150.
   PubMed Web of Science ®Google Scholar
• Ebner, R., R.-H. Chen, L. Shum, S. Lawler, T. Zioncheck, A. R. Lopez, and R. Derynck 1993. Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science 260: 1344–1348.
   PubMed Web of Science ®Google Scholar
• Feng, X.-H., E. H. Filvaroff, and R. Derynck 1995. Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J. Biol. Chem. 270: 24237–24245.
   PubMed Web of Science ®Google Scholar
• Franzén, P., P. ten Dijke, H. Ichijo, H. Yamashita, P. Schulz, C.-H. Heldin, and K. Miyazono 1993. Cloning of TGF-β type I receptor that forms a heteromeric complex with the TGF-β type I receptor. Cell 75: 681–692.
   PubMed Web of Science ®Google Scholar
• Geng, Y., and R. A. Weinberg 1993. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA 90: 10315–10319.
   PubMed Web of Science ®Google Scholar
• Goyette, M. C., K. Cho, C. L. Fasching, D. B. Levy, K. W. Kinzler, C. Paraskeva, B. Vogelstein, and E. Stanbridge 1992. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol. 12: 1387–1395.
   PubMed Web of Science ®Google Scholar
• Graycar, J. L., D. A. Miller, B. A. Arrick, R. M. Lyons, H. L. Moses, and R. Derynck 1989. Human transforming growth factor-β3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-β1 and -β2. Mol. Endocrinol. 3: 1977–1986.
   PubMed Web of Science ®Google Scholar
• Guy, G. R., R. Philp, and Y. H. Tan 1995. Activation of protein kinases and inactivation of protein phosphatase 2A in tumor necrosis factor and interleukin-1 signal-transduction pathways. Eur. J. Biochem. 229: 503–511.
   PubMedGoogle Scholar
• Hannon, G. J., and D. Beach 1994. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257–260.
   PubMed Web of Science ®Google Scholar
• Healy, A. M., S. Zolnierowicz, A. E. Stapleton, M. Goebl, A. A. DePaoli-Roach, and J. R. Pringle 1991. CDC55, a Saccharomyces cerevisiae gene involved in cellular morphogenesis: identification, characterization, and homology to the B subunit of mammalian type 2A protein phosphatase. Mol. Cell. Biol. 11: 5767–5780.
   PubMedGoogle Scholar
• Hedman, K., M. Kurkinen, K. Alitalo, A. Vaheri, S. Johansson, and M. Hook 1979. Isolation of the pericellular matrix of human fibroblast cultures. J. Cell Biol. 81: 83–91.
   PubMed Web of Science ®Google Scholar
• Heldin, C.-H. 1996. Protein tyrosine kinase receptors. Cancer Surv. 27: 7–24.
   PubMedGoogle Scholar
• Heldin, C.-H, K. Miyazono, and P. ten Dijke 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465–471.
   PubMed Web of Science ®Google Scholar
• Kamibayashi, C., R. Estes, R. L. Lickteig, S.-I. Yang, C. Craft, and M. C. Mumby 1994. Comparison of heterotrimeric protein phosphatase 2A containing different B subunits. J. Biol. Chem. 269: 20139–20148.
   PubMedGoogle Scholar
• Kato, M., A. Ishizaki, U. Hellman, C. Wernstedt, M. Kyogoku, K. Miyazono, C.-H. Heldin, and K. Funa 1995. A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner. J. Biol. Chem. 270: 12373–12379.
   PubMedGoogle Scholar
• Keeton, M. R., S. A. Curriden, A.-J. van Zonneveld, and D. J. Loskutoff 1991. Identification of regulatory sequences in the type I plasminogen activator inhibitor gene responsive to transforming growth factor β. J. Biol. Chem. 266: 23048–24052.
   PubMedGoogle Scholar
• Lagna, G., A. Hata, A. Hemmati-Brivanlou, and J. Massagué 1996. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383: 832–836.
   PubMed Web of Science ®Google Scholar
• Laiho, M., F. M. B. Weis, and J. Massague 1990. Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265: 18518–18524.
   PubMed Web of Science ®Google Scholar
• Laiho, M., F. M. B. Weis, F. T. Boyd, R. A. Ignotz, and J. Massagué 1991. Responsiveness to transforming growth factor-β (TGF-β) restored by genetic complementation between cells defective in TGF-β receptors I and II. J. Biol. Chem. 266: 9108–9112.
   PubMed Web of Science ®Google Scholar
• Lin, H. Y., X.-F. Wang, E. Ng-Eaton, R. A. Weinberg, and H. F. Lodish 1992. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775–785.
   PubMed Web of Science ®Google Scholar
• Liu, F., F. Ventura, J. Doody, and J. Massagué 1995. Human type II receptor for bone morphogenetic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol. 15: 3479–3486.
   PubMed Web of Science ®Google Scholar
• Massagué, J., A. Hata, and F. Liu 1997. TGF-β signalling through the Smad pathway. Trends Cell Biol. 7: 187–192.
   PubMed Web of Science ®Google Scholar
• Mayer, R. E., P. Hendrix, P. Cron, R. Matthies, S. R. Stone, J. Goris, W. Merlevede, J. Hofsteenge, and B. A. Hemmings 1991. Structure of the 55kDa regulatory subunit of protein phosphatase 2A: evidence for a neuronal-specific isoform. Biochemistry 30: 3589–3597.
   PubMedGoogle Scholar
• Mayer-Jaekel, R. E., H. Ohkura, R. Gomes, C. E. Sunkel, S. Baumgartner, B. A. Hemmings, and D. M. Glover 1993. The 55 kd regulatory subunit of drosophila protein phosphatase 2A is required for anaphase. Cell 72: 621–633.
   PubMed Web of Science ®Google Scholar
• Mayer-Jaekel, R. E., H. Ohkura, P. Ferrigno, N. Andjelkovic, K. Shiomi, T. Uemura, D. M. Glover, and B. M. Hemmings 1994. Drosophila mutants in the 55 kDa regulatory subunit of protein phosphatase 2A show strongly reduced ability to dephosphorylate substrates of p34cdc2. J. Cell. Sci. 107: 2609–2616.
   PubMedGoogle Scholar
• McCaffrey, T. A., D. J. Falcone, C. F. Brayton, L. A. Agarwal, F. G. Welt, and B. B. Weksler 1989. Transforming growth factor-β activity is potentiated by heparin via dissociation of the transforming growth factor-β/α2-macroglobulin inactive complex. J. Cell Biol. 109: 441–448.
   PubMed Web of Science ®Google Scholar
• McCright, B., and D. M. Virshup 1995. Identification of a new family of protein phosphatase 2A regulatory subunits. J. Biol. Chem. 270: 26123–26128.
   PubMedGoogle Scholar
• Miettinen, P. J., R. Ebner, A. R. Lopez, and R. Derynck 1994. TGF-β-induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 127: 2021–2036.
   PubMed Web of Science ®Google Scholar
• Neer, E. J., C. J. Schmidt, R. Nambudripad, and T. F. Smith 1994. The ancient regulatory-protein family of WD-repeat proteins. Nature 371: 297–300.
   PubMed Web of Science ®Google Scholar
• Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massagué 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9: 1831–1845.
   PubMed Web of Science ®Google Scholar
• Smith, D. B., and K. S. Johnson 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67: 31–40.
   PubMed Web of Science ®Google Scholar
• Sontag, E., S. Fedorov, C. Kamibayashi, D. Robbins, M. Cobb, and M. Mumby 1993. The interaction of SV40 small tumor antigen with protein kinase 2A stimulates the MAP kinase pathway and induces cell proliferation. Cell 75: 887–897.
   PubMed Web of Science ®Google Scholar
• Sontag, E., V. Nunbhakdi-Craig, G. S. Bloom, and M. C. Mumby 1995. Novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J. Cell Biol. 128: 1131–1144.
   PubMedGoogle Scholar
• Tanabe, O., T. Nagase, T. Murakami, H. Nozaki, H. Usui, Y. Nishito, H. Hayashi, H. Kagamiyama, and M. Takeda 1996. Molecular cloning of a 74-kDa regulatory subunit (B") of human protein phosphatase 2A. FEBS Lett. 379: 107–111.
   PubMedGoogle Scholar
• Tehrani, M. A., M. C. Mumby, and C. Kamibayashi 1996. Identification of a novel protein phosphatase 2A regulatory subunit highly expressed in muscle. J. Biol. Chem. 271: 5164–5170.
   PubMed Web of Science ®Google Scholar
• Tehrani, M., and M. Mumby. Unpublished data.
   Google Scholar
• Wrana, J. L., L. Attisano, J. Cárcamo, A. Zentella, J. Doody, M. Laiho, X.-F. Wang, and J. Massagué 1992. TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71: 1003–1014.
   PubMed Web of Science ®Google Scholar
• Wrana, J. L., L. Attisano, R. Wieser, F. Ventura, and J. Massagué 1994. Mechanism of activation of the TGF-β receptor. Nature 370: 341–347.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., X.-H. Feng, R.-Y. Wu, and R. Derynck 1996. Receptor-associated Mad homologues synergize to induce TGF-β response. Nature 382: 168–172.
   PubMedGoogle Scholar